User profiles for William J Hulme
 | William J HulmeBennett Institute, University of Oxford Verified email at thedatalab.org Cited by 3425 |
HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY …
Background Whether HIV infection is associated with risk of death due to COVID-19 is
unclear. We aimed to investigate this association in a large-scale population-based study in …
unclear. We aimed to investigate this association in a large-scale population-based study in …
Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an …
Background COVID-19 has disproportionately affected minority ethnic populations in the UK.
Our aim was to quantify ethnic differences in SARS-CoV-2 infection and COVID-19 …
Our aim was to quantify ethnic differences in SARS-CoV-2 infection and COVID-19 …
Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death …
Background Mortality from COVID-19 shows a strong relationship with age and pre-existing
medical conditions, as does mortality from other causes. We aimed to investigate how …
medical conditions, as does mortality from other causes. We aimed to investigate how …
Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the …
Background COVID-19 has been shown to differently affect various demographic and
clinical population subgroups. We aimed to describe trends in absolute and relative COVID-19-…
clinical population subgroups. We aimed to describe trends in absolute and relative COVID-19-…
Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY
Background Long COVID describes new or persistent symptoms at least 4 weeks after onset
of acute COVID-19. Clinical codes to describe this phenomenon were recently created. Aim …
of acute COVID-19. Clinical codes to describe this phenomenon were recently created. Aim …
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the …
…, V Mahalingasivam, EPK Parker, WJ Hulme… - bmj, 2022 - bmj.com
Objective To compare the effectiveness of sotrovimab (a neutralising monoclonal antibody)
with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients …
with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients …
Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death …
Background There is concern about medium to long-term adverse outcomes following acute
Coronavirus Disease 2019 (COVID-19), but little relevant evidence exists. We aimed to …
Coronavirus Disease 2019 (COVID-19), but little relevant evidence exists. We aimed to …
Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England
Objective To investigate whether risk of infection with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and outcomes of coronavirus disease 2019 (covid-19) differed …
coronavirus 2 (SARS-CoV-2) and outcomes of coronavirus disease 2019 (covid-19) differed …
Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health …
… Elsie MF Horne,1,2 William J Hulme,3 Ruth H Keogh,4 Tom M Palmer,1,5 Elizabeth J …
doi:10.1093/aje/kwac015 35 Kollewe J. Vaccine to stop Covid transmission should now be …
doi:10.1093/aje/kwac015 35 Kollewe J. Vaccine to stop Covid transmission should now be …
Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus …
Background Hydroxychloroquine has been shown to inhibit entry of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) into epithelial cells in vitro, but clinical studies …
syndrome coronavirus 2 (SARS-CoV-2) into epithelial cells in vitro, but clinical studies …